ONC201 in combination with carboplatin and etoposide as a novel triple drug treatment for small cell lung cancer (SCLC)

被引：0
|
作者：
Lee, Young S. [1 ]
Zhou, Lanlan [1 ]
Azzoli, Christopher [1 ]
El-Deiry, Wafik S. [1 ]
机构：
[1] Brown Univ, Providence, RI 02912 USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4056
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TREATMENT OF RELAPSE OF SMALL-CELL LUNG-CANCER IN SELECTED PATIENTS WITH THE INITIAL COMBINATION CHEMOTHERAPY CARBOPLATIN, ETOPOSIDE, AND EPIRUBICIN
    COLLARD, P
    WEYNANTS, P
    FRANCIS, C
    RODENSTEIN, DO
    THORAX, 1992, 47 (05) : 369 - 371
  • [42] TREATMENT OF RELAPSE OF SMALL-CELL LUNG-CANCER IN SELECTED PATIENTS WITH THE INITIAL COMBINATION CHEMOTHERAPY WITH CARBOPLATIN, ETOPOSIDE, AND EPIRUBICIN
    NYMAN, CR
    THORAX, 1992, 47 (08) : 668 - 668
  • [43] COMBINATION CHEMOTHERAPY WITH CARBOPLATIN, ETOPOSIDE, AND VINCRISTINE AS 1ST-LINE TREATMENT IN SMALL-CELL LUNG-CANCER
    GATZEMEIER, U
    HOSSFELD, DK
    NEUHAUSS, R
    RECK, M
    ACHTERRATH, W
    LENAZ, L
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (05) : 818 - 823
  • [44] CARBOPLATIN AND ETOPOSIDE IN EXTENSIVE SMALL-CELL LUNG-CANCER
    VIREN, M
    LIIPPO, K
    OJALA, A
    HELLE, L
    HINKKA, S
    HUOVINEN, R
    JAKOBSSON, M
    JARVINEN, M
    PALOHEIMO, S
    SALMI, R
    SALOMAA, ER
    NIKKANEN, V
    ACTA ONCOLOGICA, 1994, 33 (08) : 921 - 924
  • [45] Novel cytotoxics in small cell lung cancer (SCLC)
    Hirsh, Vera
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S245 - S246
  • [46] Carboplatin in combination with bendamustine in previously untreated patients with extensive-stage small cell lung cancer (SCLC)
    Köster, W
    Stamatis, G
    Heider, A
    Avramidis, K
    Wilke, H
    Koch, JA
    Stahl, M
    CLINICAL DRUG INVESTIGATION, 2004, 24 (10) : 611 - 618
  • [47] CARBOPLATIN AND ETOPOSIDE AS OUTPATIENT TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER
    PRONZATO, P
    LANDUCCI, M
    VAIRA, F
    VIGANI, A
    BERTELLI, G
    CHEMOTHERAPY, 1994, 40 (02) : 144 - 148
  • [48] Randomized comparison of etoposide-cisplatin vs etoposide-carboplatin and irradiation in small cell lung cancer (SCLC): Evaluation of long term survival
    Samantas, E
    Milonakis, M
    Klouvas, G
    Panoussaki, A
    Agelidou, M
    Palamidas, F
    Boleti, E
    Kosmas, E
    Papadakis, E
    Kiamouris, N
    Vardoulakis, T
    Kosmidis, P
    Pavlidis, N
    Foutzilas, G
    Skarios, DV
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1078 - 1078
  • [49] Carboplatin in Combination with Bendamustine in Previously Untreated Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
    Wolf Köster
    G. Stamatis
    A. Heider
    K. Avramidis
    H. Wilke
    J.A. Koch
    M. Stahl
    Clinical Drug Investigation, 2004, 24 : 611 - 618
  • [50] Phase II study of roniciclib in combination with cisplatin/etoposide or carboplatin/etoposide as first-line therapy in subjects with extensive-disease small cell lung cancer (ED-SCLC)
    Reck, M.
    Horn, L.
    Novello, S.
    Barlesi, F.
    Albert, I.
    Juhasz, E.
    Chung, J.
    Fritsch, A.
    Drews, U.
    Rutstein, M.
    Wagner, A.
    Govindan, R.
    ANNALS OF ONCOLOGY, 2016, 27
12345